AUPN649395A0 - A method for diagnosing alzheimer's disease - Google Patents

A method for diagnosing alzheimer's disease

Info

Publication number
AUPN649395A0
AUPN649395A0 AUPN6493A AUPN649395A AUPN649395A0 AU PN649395 A0 AUPN649395 A0 AU PN649395A0 AU PN6493 A AUPN6493 A AU PN6493A AU PN649395 A AUPN649395 A AU PN649395A AU PN649395 A0 AUPN649395 A0 AU PN649395A0
Authority
AU
Australia
Prior art keywords
disease
diagnosing alzheimer
alzheimer
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN6493A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RAMSAY HEALTH CARE Pty Ltd
WESTERN AUSTRALIA THE, University of
Original Assignee
University of Western Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Australia filed Critical University of Western Australia
Priority to AUPN6493A priority Critical patent/AUPN649395A0/en
Publication of AUPN649395A0 publication Critical patent/AUPN649395A0/en
Priority to AU74860/96A priority patent/AU7486096A/en
Priority to PCT/AU1996/000711 priority patent/WO1997018476A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AUPN6493A 1995-11-10 1995-11-10 A method for diagnosing alzheimer's disease Abandoned AUPN649395A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPN6493A AUPN649395A0 (en) 1995-11-10 1995-11-10 A method for diagnosing alzheimer's disease
AU74860/96A AU7486096A (en) 1995-11-10 1996-11-08 A method for diagnosing alzheimer's disease
PCT/AU1996/000711 WO1997018476A1 (en) 1995-11-10 1996-11-08 A method for diagnosing alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN6493A AUPN649395A0 (en) 1995-11-10 1995-11-10 A method for diagnosing alzheimer's disease

Publications (1)

Publication Number Publication Date
AUPN649395A0 true AUPN649395A0 (en) 1995-12-07

Family

ID=3790818

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN6493A Abandoned AUPN649395A0 (en) 1995-11-10 1995-11-10 A method for diagnosing alzheimer's disease

Country Status (2)

Country Link
AU (1) AUPN649395A0 (en)
WO (1) WO1997018476A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19909357A1 (en) * 1999-03-03 2000-09-07 Gerd Multhaup Copper agonist that binds to the APP copper binding site and / or has an inhibitory effect on the release of the amyloid-Aß peptide
WO2004048979A1 (en) * 2002-11-27 2004-06-10 Evotec Neurosciences Gmbh DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
JP5486808B2 (en) 2005-11-30 2014-05-07 アッヴィ・インコーポレイテッド Monoclonal antibody against amyloid beta protein and use thereof
PL1954718T3 (en) 2005-11-30 2015-04-30 Abbvie Inc Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
RS53174B (en) 2007-10-05 2014-06-30 Genentech Inc. Use of anti-amyloid beta antibody in ocular diseases
CN104744591B (en) 2010-04-15 2022-09-27 Abbvie德国有限责任两合公司 Amyloid beta binding proteins
WO2012016173A2 (en) 2010-07-30 2012-02-02 Ac Immune S.A. Safe and functional humanized antibodies
CN105348387B (en) 2010-08-14 2020-08-25 Abbvie 公司 Amyloid beta binding proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
ATE286971T1 (en) * 1991-01-21 2005-01-15 Elan Pharm Inc TEST AND MODEL FOR ALZHEIMERS DISEASE
WO1993007296A1 (en) * 1991-10-03 1993-04-15 Indiana University Foundation Method for screening for alzheimer's disease
EP0613560B2 (en) * 1991-11-12 2006-06-21 Prana Biotechnology Ltd A method for assaying and treating alzheimer's disease
US5854392A (en) * 1992-08-31 1998-12-29 Bristol-Myers Squibb Company β APP-C100 receptor

Also Published As

Publication number Publication date
WO1997018476A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
AU2414092A (en) Diagnostic method for alzheimer's disease
EP0773797A4 (en) A method of diagnosing alzheimer's disease
AU2765992A (en) Method for screening for alzheimer's disease
AU7708498A (en) Nematode model for alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU5767896A (en) Method for diagnosing schizophrenia
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
AUPN649395A0 (en) A method for diagnosing alzheimer's disease
AU6671196A (en) Method for diagnosing autoimmune diseases
AU1141197A (en) Method for diagnosing autoimmune diseases
AU8346498A (en) Method for diagnosing alzheimer disease
AU3628595A (en) Screening method for periodontal disease
AU5880596A (en) Methods and compounds for diagnosing coronary artery disease
AU1405899A (en) Treatment for alzheimer's disease
AU9017098A (en) Method for diagnosing alzheimer's disease
GB2303717B (en) Process for positioning a part
AU7201696A (en) Method of diagnosing crohn's disease
AU7497396A (en) Device for determining the shape of a horse's back
AU7486096A (en) A method for diagnosing alzheimer's disease
AUPN058895A0 (en) Diagnostic method
AU3400797A (en) A method for treating meniere's disease
AU2990692A (en) Diagnostic method for pompe's disease
GB9510401D0 (en) "A jig for locks"
AU5104696A (en) A method for identifying a novel multidrug-resistance type
AUPN192695A0 (en) Diagnosis method